Vireo Growth (VREOF) Gross Profit Growth (1y) (2021 - 2026)
Vireo Growth (VREOF) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 5.06% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 2.59% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -18.38% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -7.66% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -0.34% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 42.12% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 14.77% |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 378.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 378.23% |
| Dec 31, 2025 | 349.59% |
| Sep 30, 2025 | 203.34% |
| Jun 30, 2025 | 50.68% |
| Mar 31, 2025 | 1.27% |
| Dec 31, 2024 | 4.95% |
| Sep 30, 2024 | -6.62% |
| Jun 30, 2024 | 45.22% |
| Mar 31, 2024 | 28.62% |
| Dec 31, 2023 | 41.57% |
| Sep 30, 2023 | 38.38% |
| Jun 30, 2023 | -9.99% |
| Mar 31, 2023 | 282.54% |
| Dec 31, 2022 | 295.16% |
| Sep 30, 2022 | 86.45% |
| Jun 30, 2022 | 49.97% |
| Mar 31, 2022 | -55.68% |
| Dec 31, 2021 | -59.30% |
| Sep 30, 2021 | 3.05% |
| Jun 30, 2021 | 92.53% |